Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1801514rdf:typepubmed:Citationlld:pubmed
pubmed-article:1801514lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1801514lifeskim:mentionsumls-concept:C0734999lld:lifeskim
pubmed-article:1801514lifeskim:mentionsumls-concept:C0015928lld:lifeskim
pubmed-article:1801514lifeskim:mentionsumls-concept:C0006558lld:lifeskim
pubmed-article:1801514lifeskim:mentionsumls-concept:C0033362lld:lifeskim
pubmed-article:1801514lifeskim:mentionsumls-concept:C0061309lld:lifeskim
pubmed-article:1801514lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:1801514pubmed:issue1lld:pubmed
pubmed-article:1801514pubmed:dateCreated1992-4-23lld:pubmed
pubmed-article:1801514pubmed:abstractTextThe presence of C-peptide, proinsulin, insulin-A-chain, and glicentin in human fetal pancreatic cells by using the PAP-technique was investigated and the results obtained compared with the occurrence of insulin or glucagon immunoreactive cells. In pancreatic sections obtained from 10 weeks old human fetuses we could identify cells reacting with antibodies directed against C-peptide, proinsulin, and insulin-A-chain. The majority of the cells were found in the duct epithelium and their number increased from the 10th to 14th week forming clusters near the ducts. The number and localization of the cells correspond exactly to the insulin positive cells. The presence of proinsulin and insulin-A-chains is a further proof of biological activity already in an early step of fetal development. The presence of glicentin-positive cells in the 10th week of gestational age as well as cells reacting with glucagon antibodies provide evidence for active glucagon biosynthesis. The number of these cells increased markedly in the 14th week of gestational age.lld:pubmed
pubmed-article:1801514pubmed:languageenglld:pubmed
pubmed-article:1801514pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801514pubmed:citationSubsetIMlld:pubmed
pubmed-article:1801514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801514pubmed:statusMEDLINElld:pubmed
pubmed-article:1801514pubmed:issn0065-1281lld:pubmed
pubmed-article:1801514pubmed:authorpubmed-author:HahnH JHJlld:pubmed
pubmed-article:1801514pubmed:authorpubmed-author:von...lld:pubmed
pubmed-article:1801514pubmed:authorpubmed-author:HallD PDPlld:pubmed
pubmed-article:1801514pubmed:authorpubmed-author:ReiherHHlld:pubmed
pubmed-article:1801514pubmed:authorpubmed-author:MadsenOOlld:pubmed
pubmed-article:1801514pubmed:issnTypePrintlld:pubmed
pubmed-article:1801514pubmed:volume91lld:pubmed
pubmed-article:1801514pubmed:ownerNLMlld:pubmed
pubmed-article:1801514pubmed:authorsCompleteYlld:pubmed
pubmed-article:1801514pubmed:pagination39-42lld:pubmed
pubmed-article:1801514pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:meshHeadingpubmed-meshheading:1801514-...lld:pubmed
pubmed-article:1801514pubmed:year1991lld:pubmed
pubmed-article:1801514pubmed:articleTitleDetection of proinsulin, C-peptide, insulin-A-chain, and glicentin in pancreatic islet cells of early human fetogenesis.lld:pubmed
pubmed-article:1801514pubmed:affiliationErnst Moritz Arndt University, Institute of Anatomy, Greifswald, Germany.lld:pubmed
pubmed-article:1801514pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1801514pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1801514pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed